⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Atossa Therapeutics, Inc. Common Stock

$2.49
+0.04 (+1.63%)

Volume:

7.035K ($17.36K)

Market Capitalization:

$24.85M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Atossa Therapeutics Market Segments

Regular Trading Hours

+0.08(+3.32%)
Open$2.41
Close$2.49
Low$2.41
Low Change0.00 (0.00%)
High$2.49
High Change+0.08 (+3.32%)
Range$0.08
Volume5.273K
Dollar Volume$13.13K

Premarket

-0.09(-3.61%)
Open$2.49
Close$2.40
Low$2.40
Low Change-0.09 (-3.61%)
High$2.50
High Change+0.01 (+0.40%)
Range$0.10
Volume1.762K
Dollar Volume$4.23K

Overnight

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$2.45
Close$2.45
Low$2.45
Low Change0.00 (0.00%)
High$2.45
High Change+0.00 (+0.00%)
Range$0.00
Volume714
Dollar Volume$1.75K

Regular Trading Hours Yesterday

-0.01(-0.41%)
Open$2.46
Close$2.45
Low$2.43
Low Change-0.03 (-1.22%)
High$2.54
High Change+0.08 (+3.25%)
Range$0.11
Volume49.839K
Dollar Volume$122.11K

Premarket Yesterday

+0.01(+0.43%)
Open$2.34
Close$2.35
Low$2.34
Low Change0.00 (0.00%)
High$2.40
High Change+0.06 (+2.56%)
Range$0.06
Volume1.979K
Dollar Volume$4.65K

Atossa Therapeutics Top Trades

Atossa Therapeutics's top trade so far today returned +3.75%, while the top short trade returned -4.00%.

Atossa Therapeutics Moving Averages

5 Day Moving Average (SMA5)$2.29
10 Day Moving Average (SMA10)$2.15
20 Day Moving Average (SMA20)$2.26
50 Day Moving Average (SMA50)$2.39
100 Day Moving Average (SMA100)$2.81
200 Day Moving Average (SMA200)$4.61

Atossa Therapeutics Statistics

Average Volume (30 Days)58.19K
P/E Ratio (Current)-.65
EPS (Current)-$3.78
Dividend Yield0.00%
Free Cash Flow-$35.78M
Cash Ratio4.79
Current Ratio5.69
Quick Ratio5.14
Debt to Equity0.00
Enterprise Value-$1.64M
EV to EBITDA0.04
EV to Sales—
Price to Book0.91
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets-1.17%
Return on Equity-1.41%

Atossa Therapeutics Stock Splits

There have been 3 stock splits for Atossa Therapeutics (ATOS). The last reverse stock split occured on February 2, 2026 and reduced the outstanding shares at a ratio of 15:1.

DateTypeRatio
Feb 2, 2026Reverse15:1
Apr 20, 2018Reverse12:1
Aug 26, 2016Reverse15:1

Atossa Therapeutics Dividends

There have been no dividends for Atossa Therapeutics (ATOS).